Lupus pernio is a specific cutaneous manifestation of sarcoidosis characterised by chronic, indurated skin lesions. When systemic treatment is indicated, a structured pharmacological approach is used to manage the condition.
First-line management involves systemic corticosteroid therapy. The regimen is built around oral corticosteroids, with specific agent selection and dosing outlined in the full protocol.